Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1
Top Cited Papers
Open Access
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 131 (2), 470-477
- https://doi.org/10.1053/j.gastro.2006.06.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1Hepatology, 2004
- Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsGut, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Projecting future complications of chronic hepatitis C in the United StatesLiver Transplantation, 2003
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Hepatitis C in African Americans: Summary of a workshopGastroenterology, 2000
- Racial differences in responses to therapy with interferon in chronic hepatitis CHepatology, 1999